PSMA Response in Metastasized Hormone Sensitive Prostate Cancer (PET-MaN)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05161728 |
Recruitment Status :
Recruiting
First Posted : December 17, 2021
Last Update Posted : January 9, 2024
|
Sponsor:
Roderick van den Bergh
Information provided by (Responsible Party):
Roderick van den Bergh, UMC Utrecht
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | October 19, 2025 |
Estimated Study Completion Date : | October 19, 2025 |